{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:11Z","timestamp":1793608031378,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129133","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:42:55Z","timestamp":1789760575000},"page":"129133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A randomised, double-blind, placebo-controlled phase I clinical trial to evaluate the safety, tolerability and immunogenicity of three doses of an adjuvanted group B Streptococcus vaccine in older adults aged 55 to 75"],"prefix":"10.1016","volume":"92","author":[{"given":"Lidia","family":"Oostvogels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Alhatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"De Gussem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebbe","family":"Englev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per B.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Johansson-Lindbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Kitson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenn","family":"Waerlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Leroux-Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129133_bb0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fmicb.2018.00437","article-title":"Group B streptococcal colonization, molecular characteristics, and epidemiology","volume":"9","author":"Shabayek","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.vaccine.2026.129133_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12884-023-05478-9","article-title":"The risk factors for group B Streptococcus colonization during pregnancy and influences of intrapartum antibiotic prophylaxis on maternal and neonatal outcomes","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Pregnancy Childbirth."},{"key":"10.1016\/j.vaccine.2026.129133_bb0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s15010-022-01965-x","article-title":"Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center study","volume":"51","author":"Lohrmann","year":"2023","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2026.129133_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258030","article-title":"Burden of invasive group B Streptococcus disease in non-pregnant adults: a systematic review and meta-analysis","volume":"16","author":"Navarro-Torn\u00e9","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.129133_bb0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/23744235.2015.1131330","article-title":"The changing epidemiology of group B Streptococcus bloodstream infection: a multi-national population-based assessment","volume":"48","author":"Ballard","year":"2016","journal-title":"Infect Dis. (Lond)"},{"key":"10.1016\/j.vaccine.2026.129133_bb0030","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/432804","article-title":"Group B streptococcal infections in elderly adults","volume":"41","author":"Edwards","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129133_bb0035","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/322696","article-title":"Group B streptococcal disease in nonpregnant adults","volume":"33","author":"Farley","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129133_bb0040","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1128\/JCM.05488-11","article-title":"Dominance of serotype Ia among group B streptococci causing invasive infections in nonpregnant adults in Portugal","volume":"50","author":"Martins","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2026.129133_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy030","article-title":"Obesity, diabetes, and the risk of invasive group B streptococcal disease in nonpregnant adults in the United States","volume":"5","author":"Pitts","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129133_bb0050","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/infdis\/jiaa110","article-title":"Burden of adults hospitalized with group B streptococcal infection","volume":"224","author":"McLaughlin","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129133_bb0055","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1017\/S0950268815000606","article-title":"Group B Streptococcus infections of soft tissue and bone in California adults, 1995\u20132012","volume":"143","author":"Smith","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.vaccine.2026.129133_bb0060","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1089\/mdr.2018.0246","article-title":"Fluoroquinolone-resistant Streptococcus agalactiae invasive isolates recovered in Argentina","volume":"25","author":"Arias","year":"2019","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.vaccine.2026.129133_bb0065","article-title":"Molecular characteristics and antibiotic resistance mechanisms of clindamycin-resistant Streptococcus agalactiae isolates in China","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.vaccine.2026.129133_bb0070","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.21.1700473","article-title":"Increasing macrolide resistance among Streptococcus agalactiae causing invasive disease in non-pregnant adults was driven by a single capsular-transformed lineage, Portugal, 2009 to 2015","volume":"23","author":"Lopes","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2026.129133_bb0075","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/JCM.01183-16","article-title":"Molecular characteristics of group B streptococci isolated from adults with invasive infections in Japan","volume":"54","author":"Morozumi","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2026.129133_bb0080","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/ciaa151","article-title":"Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive group B streptococci within the United States, 2015\u20132017","volume":"72","author":"McGee","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129133_bb0085","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.vaccine.2020.08.052","article-title":"Systematic review of group B streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates","volume":"38","author":"Bianchi-Jassir","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129133_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1128\/CVI.00643-14","article-title":"Survey of immunological features of the alpha-like proteins of Streptococcus agalactiae","volume":"22","author":"Maeland","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.vaccine.2026.129133_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106261","article-title":"Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial","volume":"26","author":"Gonzalez-Miro","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.vaccine.2026.129133_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127820","article-title":"Safety and immunogenicity of a single booster dose of the group B streptococcus AlpN candidate vaccine (GBS-AlpN) in previously vaccinated healthy women compared with a single dose in previously unvaccinated women","volume":"65","author":"Johansson-Lindbom","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129133_bb0105","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1473-3099(25)00659-0","article-title":"Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study","volume":"26","author":"Heath","year":"2026","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129133_bb0110","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1016\/j.vaccine.2020.11.002","article-title":"Understanding immunosenescence and its impact on vaccination of older adults","volume":"38","author":"Allen","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129133_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12979-023-00361-9","article-title":"Obesity accelerates age defects in B cells, and weight loss improves B cell function","volume":"20","author":"Frasca","year":"2023","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.vaccine.2026.129133_bb0120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10096-020-04041-0","article-title":"Invasive group B Streptococcus among non-pregnant adults in Brussels-capital region, 2005\u20132019","volume":"40","author":"Graux","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129133_bb0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.vaccine.2026.129133_bb0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.maturitas.2015.05.004","article-title":"Immunosenescence: implications for response to infection and vaccination in older people","volume":"82","author":"Pera","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.vaccine.2026.129133_bb0135","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.299.17.2056","article-title":"Epidemiology of invasive group B streptococcal disease in the United States, 1999\u20132005","volume":"299","author":"Phares","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.129133_bb0140","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/07853890.2021.1930138","article-title":"Incidence of invasive group B Streptococcus (iGBS) infections and the factors associated with iGBS mortality in adults during 2013-2017: a retrospective study at Thailand\u2019s largest national tertiary referral center","volume":"53","author":"Phoompoung","year":"2021","journal-title":"Ann. Med."},{"key":"10.1016\/j.vaccine.2026.129133_bb0145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7861\/clinmed.23-6-s46","article-title":"Group B streptococcus-associated invasive infections in the adult, non-pregnant population; incidence, risk factors, and clinical presentations beyond borders","volume":"23","author":"Razok","year":"2023","journal-title":"Clin. Med. (Lond)"},{"key":"10.1016\/j.vaccine.2026.129133_bb0150","doi-asserted-by":"crossref","first-page":"1490302","DOI":"10.3389\/fragi.2024.1490302","article-title":"The 3 I\u2019s of immunity and aging: immunosenescence, inflammaging, and immune resilience","volume":"5","author":"Wrona","year":"2024","journal-title":"Front. Aging"},{"key":"10.1016\/j.vaccine.2026.129133_bb0155","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/00003495-200363100-00006","article-title":"Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B","volume":"63","author":"Keating","year":"2003","journal-title":"Drugs"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2026.129133_bb0160","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.vaccine.2005.04.019","article-title":"The unmet need in the elderly: designing new influenza vaccines for older adults","volume":"23","author":"McElhaney","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129133_bb0165","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/ijo.2011.208","article-title":"Obesity is associated with impaired immune response to influenza vaccination in humans","volume":"36","author":"Sheridan","year":"2012","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.vaccine.2026.129133_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3601","article-title":"Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a 6 months follow-up study: the CoVaDiab study I","volume":"39","author":"D\u2019Onofrio","year":"2023","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.vaccine.2026.129133_bb0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000504440","article-title":"The impact of obesity and metabolic syndrome on vaccination success","volume":"43","author":"Frasca","year":"2020","journal-title":"Interdiscip. Top Gerontol. Geriatr."},{"key":"10.1016\/j.vaccine.2026.129133_bb0180","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/14760584.2020.1760098","article-title":"Diabetes mellitus as a vaccine-effect modifier: a review","volume":"19","author":"Verstraeten","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.vaccine.2026.129133_bb0185","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2026.129133_bb0190","series-title":"Immunogenicity and safety of GBS-NN\/NN2 in pregnant women (NCT05154578)","author":"ClinicalTrials.gov","year":"2026"},{"key":"10.1016\/j.vaccine.2026.129133_bb0195","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1016\/j.vaccine.2015.10.019","article-title":"Correlates of protection of serotype-specific capsular antibody and invasive group B Streptococcus disease in south African infants","volume":"33","author":"Dangor","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129133_bb0200","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/QCO.0000000000000266","article-title":"Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections","volume":"29","author":"Dangor","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2026.129133_bb0205","doi-asserted-by":"crossref","first-page":"D52","DOI":"10.1016\/j.vaccine.2013.02.029","article-title":"Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants","volume":"31","author":"Madhi","year":"2013","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:40:22Z","timestamp":1793605222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S0264410X26009424"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129133","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomised, double-blind, placebo-controlled phase I clinical trial to evaluate the safety, tolerability and immunogenicity of three doses of an adjuvanted group B Streptococcus vaccine in older adults aged 55 to 75","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 MinervaX Asp. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129133"}}